MedPath

A clinical study to compare the effect of 0.074% Diclofenac sodium mouthwash and 50 mg diclofenac sodium tablet in reduction of pain and swelling after gum surgery for pyorrhea.

Not Applicable
Conditions
Health Condition 1: null- Patients indicated for conventional periodontal flap surgery
Registration Number
CTRI/2018/01/011352
Lead Sponsor
one
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients having periodontal pocket depth ranging from 5mm to 8mm.

2.Patients indicated for periodontal surgery bilaterally in same arch.

3.Systemically healthy patients.

Exclusion Criteria

1.Patients having endo-perio lesions.

2.Patients requiring resective osseous surgery or regenerative osseous surgery.

3.Patients with the history of intolerance or hypersensitivity to diclofenac.

4.Any systemic diseases or condition that affects the oral tissues,

5.Pregnant or lactating women.

6.Acute gingival or periodontal disease.

7.Patients on oral/systemic NSAIDs therapy for the last three months.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Diclofenac sodium local application (0.074% mouthwash) will have equal analgesic effect as compared to its systemic administration (tablet), but it would be better in terms of its anti-inflammatory effect and patientâ??s acceptability when used after periodontal flap surgery.Timepoint: Analgesic effect will checked on 1st 2nd 3rd and 4th day after surgery. Inflammation will be assessed after 7 days 1 month and 3 months after surgery.
Secondary Outcome Measures
NameTimeMethod
oneTimepoint: None
© Copyright 2025. All Rights Reserved by MedPath